Latest updates for Abbv:ca

Fresh curated links around ABBV:CA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst
  • Abbott forecasts 6.5%-7.5% 2026 comparable sales growth while integrating Exact Sciences with $0.20 EPS dilution
  • Abbott Laboratories: A Dividend Aristocrat With A Compelling Valuation And Return Potential

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 day ago

Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst

Read source
seekingalpha.com /1 month ago

Abbott forecasts 6.5%-7.5% 2026 comparable sales growth while integrating Exact Sciences with $0.20 EPS dilution

Read source
seekingalpha.com /1 month ago

Abbott Laboratories: A Dividend Aristocrat With A Compelling Valuation And Return Potential

Read source
seekingalpha.com /1 month ago

AbbVie: Upside Potential And Dividends With Competent Portfolio Renewal

Read source
seekingalpha.com /2 weeks ago

Alfen N.V. (ABHBY) Q1 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Abbott Laboratories: Buying A Healthcare Giant On Sale

Read source
seekingalpha.com /4 weeks ago

Air Canada (AC:CA) Shareholder/Analyst Call Transcript

Read source
seekingalpha.com /1 month ago

Ambev slips after UBS warns valuation is too high

Read source
finance.yahoo.com /5 days ago

Two Paths to Growth: Johnson & Johnson vs AbbVie

Read source
seekingalpha.com /1 month ago

AB Dynamics plc 2026 Q2 - Results - Earnings Call Presentation

Read source
seekingalpha.com /4 weeks ago

Air Canada (AC:CA) Q1 2026 Earnings Call Transcript

Read source
seekingalpha.com /2 weeks ago

ArriVent BioPharma: Stronger Balance Sheet And Pipeline Upside Reinforce Our Bull Case

Read source
seekingalpha.com /1 month ago

Allied Gold Non-GAAP EPS of $0.56, revenue of $209.27M

Read source
seekingalpha.com /1 month ago

Broadcom: Multi-Year Growth Visibility For Sale At ~0.5x PEG

Read source
finance.yahoo.com /1 month ago

Abbott Laboratories Q1 2026 Earnings Call Summary

Read source
fool.com /1 month ago

Why AbbVie Is a No-Brainer Stock to Buy on the Dip

The pharma giant is still a rock-solid dividend stock.

Read source
fool.com /1 month ago

Stock Market Today, April 2: Ambev Slips as Analyst Ratings Temper Sentiment

On April 2, 2026, a fresh downgrade, elevated volume, and rising institutional interest put this brewer’s risk‑reward in sharp focus.

Read source
pharmexec.com /1 month ago

<![CDATA[Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement]]>

Read source
seekingalpha.com /2 weeks ago

Bavarian Nordic A/S 2026 Q1 - Results - Earnings Call Presentation

Read source
seekingalpha.com /1 month ago

Abbott ordered to pay $70M in damages in Chicago baby formula case

Read source
pharmexec.com /1 month ago

<![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]>

Read source
seekingalpha.com /5 days ago

Brookfield renews normal course issuer bid

Read source
seekingalpha.com /2 weeks ago

ADF Group: Upgrading After The Backlog Reset

Read source
seekingalpha.com /1 month ago

AGF Management Limited (AGF.B:CA) Q1 2026 Earnings Call Transcript

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Abbv:ca

seekingalpha.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source